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The intestinal mucosa is exposed to large amounts of foreign antigen (Ag) derived from
commensal bacteria, dietary Ags, and intestinal pathogens. Dendritic cells (DCs) are
believed to be involved in the induction of tolerance to harmless Ags and in mounting
protective immune responses to pathogens and, as such, to play key roles in regulat-
ing intestinal immune homeostasis. The characterization of classical DCs (cDCs) in the
intestinal lamina propria has been under intense investigation in recent years but the
use of markers (including CD11c, CD11b, MHC class II), which are also expressed by
intestinal Ms, has led to some controversy regarding their definition. Here we review
recent studies that help to distinguish cDCs subsets from monocyte-derived cells in the
intestinal mucosa. We address the phenotype and ontogeny of these cDC subsets and
highlight recent findings indicating that these subsets play distinct roles in the regulation
of mucosal immune responses in vivo.
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Introduction
Dendritic cells (DCs) are present throughout most tissues of the
body where their main function is to sample self and foreign anti-
gens (Ags), migrate to draining lymph nodes (LNs), and present
antigenic peptides to na¨ıve T cells, inducing their proliferation and
differentiation. In so doing, DCs provide a critical link between the
innate and adaptive immune systems. The intestinal lumen con-
tains huge quantities of foreign Ag derived from commensal bac-
teria, dietary components, and occasional pathogenic microbes.
Intestinal DCs are believed to play a central role in intestinal
immune homeostasis, by inducing tolerance to harmless Ags, ini-
tiating protective immunity against intestinal pathogens, and con-
Correspondence: Prof. William W. Agace
e-mail: william.agace@med.lu.se
tributing to intestinal diseases including celiac disease and the
inflammatory bowel diseases (IBD, Crohn’s disease, and ulcera-
tive colitis).
Classical DCs (cDCs) are found throughout the intestinal
lamina propria (LP), in gut-associated lymphoid tissue (GALT)
including Peyer’s patches (PPs) and isolated lymphoid folli-
cles (ILFs), and in intestinal draining LNs such as the mesen-
teric LNs (MLNs). In the MLNs, cDCs can be broadly classi-
fied into lymphoid tissue resident cDCs, which are thought to
derive from circulating precursors that enter directly from the
blood, and migratory cDCs that arrive in organized lymphoid tis-
sues via afferent lymph after acquiring Ag in the intestinal LP.
While lymphoid tissue cDCs have been studied extensively, the
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Figure 1. Phenotypic characterization of MPs in the SI LP. Representative flow cytometry plots of MPs in the steady-state SI LP of CX3CR1gfp/wt mice
(PPs are removed prior to analysis). Leukocytes are identified among live cells as CD45+. Monocytes/ Ms are identified among the CD11c+MHCII+
cells as CD64+ cells, and cDCs are identified as CD64− cells. cDCs can be separated into two major subsets of CD103+ cells: CD103+CD11b+ cDCs
and CD103+CD11b− cDCs, both of which are CX3CR1lo/−. In addition there is a minor population of CD103− cDCs that express variable levels of
CD11b, the majority of which are CX3CR1int. The CD11b− cells within this latter population are not present in intestinal preparations of RORγt−/−
mice, which lack PPs and ILFs, suggesting they derive from GALT and not intestinal LP [5].
functions of the intestinal cDCs that migrate to MLNs are less well
understood.
The characterization of cDCs in the intestinal LP has been
the subject of intense investigation and controversy, in part
because the markers initially used to define them (including
CD11c, CD11b and MHC class II (MHCII)) are also expressed
by Ms. In this review we discuss recent findings that have
started to unravel the complexity of migratory intestinal cDCs,
including assessment of the precursor-product relationships of
transferred monocytes and cDC precursors, the identification of
novel markers that appear to distinguish cDCs and monocyte-
derived Ms and new models that shed light on their in vivo
functionality.
Defining cDC subsets in the intestinal
mucosa
Although cDCs and other mononuclear phagocytes (MPs) such
as monocytes and monocyte-derived Ms in steady-state mouse
LP can all express MHCII and CD11c, cDCs can be distinguished
by their lack of expression of the high-affinity IgG receptor
FcγR1, CD64 [1, 2] (Fig. 1). CD64+ MPs do not express the inte-
grin αE chain CD103 and include all CX3CR1high cells that we,
and others, have shown to be tissue resident Ms [1–3]. The
CD64+ population also contains a subset of CX3CR1int cells that
co-express F4/80 and can be generated from adoptively trans-
ferred Ly6Chigh monocytes. These cells represent intermediaries
in the local differentiation of resident Ms [1, 2]. In contrast,
CD11c+MHCII+CD64− MPs are F4/80− and the majority of these
cells express CD103. These CD103+ DCs have been held to be
the prototypic migratory cDCs in the LP and can be divided
into two main populations, CD103+CD11b+ and CD103+CD11b−
cDCs (Fig. 1). These subsets differ in their localization, transcrip-
tion factor requirements, and function. Finally, there is a dis-
tinct population of CD11c+MHCII+CD103− MPs in the intestine,
which lack expression of the monocyte/M marker CD64 [4],
and express heterogeneous levels of CD11b (Fig. 1). As will be
discussed below, several lines of evidence suggest that these cells
are bona fide migratory cDCs. Notably, intestinal CD103−CD11b−
but not CD103−CD11b+ cDC numbers are significantly reduced in
RORγt−/− mice that lack PPs and ILFs, suggesting that the former
are GALT derived while the latter are resident within the intestinal
LP [5].
Ontogeny of intestinal cDC subsets
Intestinal cDC precursors
According to current models, cDCs derive from committed cDC
progenitors that develop in the bone marrow (BM) and travel
via the blood to lymphoid organs and nonlymphoid tissues,
where they differentiate into mature cDCs [6–9]. Adoptive trans-
fer studies have demonstrated that pre-cDCs, but not mono-
cytes, give rise to both CD103+CD11b+ and CD103+CD11b−
cDCs in the intestinal LP [10, 11]. In addition, a subset of
lineage−CD11c+α4β7+B220+CCR9− cells termed premucosal DC
progenitors was recently identified, which appeared, upon adop-
tive transfer, to home preferentially to the intestinal mucosa and
give rise to both CD103+ cDC subsets [12]. While these findings
open up the intriguing possibility that there may be dedicated
subsets of ‘gut-homing’ cDC progenitors, it is of note that these
cells also gave rise to splenic cDCs (preferentially CD8α+ cDCs)
and, in contrast to pre-cDCs, they also maintained the potential to
develop into plasmacytoid DCs [12]. Despite these findings, the
relative contribution of different progenitor subsets to the develop-
ment of the intestinal LP CD103+ cDC compartment in the steady
state remains unclear. It is also unknown whether there are dis-
tinct precursors for CD103+CD11b+ and CD103+CD11b− cDCs
within these putative progenitor populations, or whether the final
differentiation state of the precursors is determined by signals
they receive within the intestinal environment. In this regard it is
of interest to note that the relative proportion of CD103+CD11b+
and CD103+CD11b− cDCs changes throughout the intestine, with
CD103+CD11b+ cDCs comprising ∼70% of total CD103+ cDCs
in the duodenum and CD103+CD11b− cDCs comprising ∼75%
of total CD103+ cDCs in the colon [13]. CD103+CD11b− cDCs
dominate over CD103+CD11b+ cDCs in GALT [11], however,
CD103+CD11b− cDCs are present in normal numbers in the intes-
tine of RORγt−/− mice suggesting that they do not require GALT
for their final differentiation and development [5].
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The identity of the precursors of CD64−CD103−CD11b+ MPs
remains unclear, as most studies that have assessed precur-
sor differentiation in the intestine to date have not used CD64
or other appropriate markers to distinguish DCs from CD11b+
Ms. As a result, it was frequently concluded that many or all
CD103−CD11b+ MPs were derived from monocytes [3, 10, 11].
However, two recent reports showed that adoptive transfer of
Ly6Chigh monocytes gave rise exclusively to F4/80+CD64+ Ms
and not CD64−CD11b+ MPs in the steady state, strongly indi-
cating that the latter cells do not derive from monocytes [1, 2].
These findings may explain why a small population of CX3CR1int
cells was observed in the LP following transfer of pre-cDCs [10],
althoughwhether these cells lacked CD64 or F4/80 expressionwas
not assessed in this study. More recently, systemic administration
of anti-CCR2 antibody was shown to deplete CX3CR1intLy6Clow
cells expressing the DC-specific transcription factor Zbtb46 in DSS
colitis [14]. These findings are intriguing in view of the usual
association of CCR2 with monocyte-derived MPs, and indicate the
need for further studies of the progenitors of this subset of cDCs
in the intestinal LP.
Transcriptional factor requirements for intestinal cDC
subsets
It is now clear that the development of the intestinal
CD103+CD11b− and CD103+CD11b+ cDC subsets is dependent
on distinct transcription factors. Peripheral tissue CD103+CD11b−
cDCs, including those located in the intestinal LP and PPs, are
dependent on basic leucine zipper transcription factor ATF-like
3 (Batf3), inhibitor of DNA-binding 2 (Id2), and IFN-regulatory
factor 8 (IRF8) [9, 11, 15–17] (Fig. 2). CD103+CD11b−
cDCs therefore appear developmentally linked to IRF8/Batf3-
dependent lymphoid tissue resident CD8α+ cDCs [15, 18, 19].
Supporting this idea, CD103+CD11b− cDCs in LP express CD8α
[5,20] and other markers typical of CD8α+ lymphoid cDCs, includ-
ing the chemokine receptor XCR1 [21, 22] and the C-type lectin
DNGR-1 [23], and lack expression of DC inhibitory receptor 2
(DCIR2) [24] and signal regulatory protein (SIRP) α [5,24]. Con-
versely CD103+CD11b+ intestinal cDCs develop independently
of IRF8, Id2, and Batf3 [9, 16], and recent data from us, and
others, suggest they may be developmentally related to splenic
CD11b+CD4+ DCs [24,25]. Both these populations of DCs express
high levels of SIRPα and DCIR2 [5, 24], and lack expression of
XCR1 [21,22]. Furthermore, we and others recently demonstrated
that CD11c-Cre.IRF4fl/fl mice, whose DCs lack the transcription
factor IRF4, referred to here as IRF4 DC mice, have significantly
reduced numbers of intestinal CD103+CD11b+ cDCs [4, 24], as
well as reduced numbers of splenic and LN resident CD11b+
DCs [24], together with a dramatic reduction in CD103+CD11b+
cDC numbers in intestinal draining MLNs [4, 24]. Intestinal
CD103+CD11b+ cDCs isolated from IRF4 DC mice died more
rapidly in vitro compared with WT CD103+CD11b+ cDCs, and the
few CD103+CD11b+ cDCs that remained in the MLNs of IRF4
Figure 2. Overview of intestinal MPs. Ly6Chi monocytes and cDC
precursors seed the intestine from the blood where they give rise
to distinct populations of MPs. cDC precursors, but not mono-
cytes, give rise to CD103+CD11b− and CD103+CD11b+ cDCs whose
development/maintenance depends on distinct transcription fac-
tors. CD103+CD11b− cDC are dependent on BatF3, IRF8, and Id2;
CD103+CD11b+ cDC on IRF4 and Notch2. In the absence of IRF4 (IRF4)
CD103+CD11b+ cDC survival is compromised. It is currently unclear
whether cDC precursors entering the intestine are precommitted to
developing into one or other of these populations or whether the same
precursor can develop into either subset depending on the signals it
receives within the intestinal environment. In addition to CD103+ cDCs
there is a minor population of CD103−CD64−CD11b+ cells in intesti-
nal LP [4, 5], which likely represent bona fide cDCs (see main text).
In contrast to CD64− cDCs, CD64+ Ms develop from Ly6Chi mono-
cytes through a series of intermediate steps during which they lose the
expression of Ly6C and gain expression of MHC class II [1,2].
DC mice expressed Annexin V. Together these results indicate
a key role for IRF4 in intestinal CD103+CD11b+ cDC survival
([24], Fig. 2). Interestingly, mice with a DC-specific deletion in
Notch-2 also display reduced numbers of both CD103+CD11b+
intestinal cDCs and a subset of splenic CD4+CD11b+ cDCs [25],
providing additional evidence for a developmental link between
these populations. CD11b+ lymphoid resident cDC homeostasis
is also perturbed in TNF receptor-associated factor-6 (TRAF-6),
IRF2, and Rel-B-deficient mice [26–28], but whether these factors
contribute to intestinal CD103+CD11b+ cDC homeostasis remains
to be explored. The transcription factor requirements for CD103−
cDCs remain to be determined.
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA Weinheim.
www.eji-journal.eu
4 Emma K. Persson et al. Eur. J. Immunol. 2013. 00: 1–10
Growth factor requirements
cDC development and homeostasis are regulated by the growth
factors FMS-like tyrosine kinase 3 ligand (Flt3L) and granulocyte
M colony-stimulating factor (GM-CSF/CSF-2) [29]. The recep-
tor for Flt3L (Flt3/CD135) is expressed on cDCs throughout their
development, as well as on mature cells [7] and Flt3L induces
cDC development from BM progenitors in vitro [30]. Mice lacking
the Flt3 receptor (Flt3−/− mice) have a severe reduction in both
CD103+CD11b− and CD103+CD11b+ intestinal LP cDC numbers
[11]. While administration of exogenous Flt3L expands both sub-
sets of intestinal CD103+ cDCs, it has a greater impact on intestinal
CD103+CD11b− cDCs [5, 24] and DC-specific deletion of Pten, a
negative regulator of Flt3L-induced PI3K-mTOR signaling, leads to
increased numbers of intestinal CD103+CD11b− cDCs [31]. Col-
lectively, these results demonstrate that Flt3L plays an important
role in CD103+ cDC homeostasis. The role of CSF-2 in intestinal
cDC development is less clear. Although utilized for generating
human and murine DCs from blood monocytes and BM, respec-
tively, in vitro [32], mice lacking CSF-2 or its receptor have normal
numbers and proportions of LN DCs [33]. Nevertheless, studies in
CSF2R KO mice (Csf2rb−/− and Csf2rb−/− × Csf2rb2−/−), CSF-2
KO mice (CSF2−/−) and in WT mice following administration of
exogenous CSF-2 have suggested that the homeostasis of intestinal
CD103+CD11b+ DCs depends upon CSF-2 [10,11,34]. However,
as CSF-2 can induce the expression of CD103 on cDCs [35, 36]
and cDCs from the lung and kidney of Csf2rb−/− × Csf2rb2−/−
mice show a defect in CD103 upregulation [34], care needs to
be exercised when using CD103 as a marker to define DCs in
mice lacking CSF-2 function. To resolve this issue, future work on
the role of CSF-2 in the development and homeostasis of intesti-
nal DC subsets should use additional markers, such as XCR1,
CD24, and CD8α, combined with CD11b or SIRPα, to define these
subsets.
Whether CSF-2 or Flt3L is required for the development of
the intestinal CD103− cDCs is currently unclear. Administration
of exogenous Flt3L to mice results in a significant expansion of
both CD103−CD11b− and CD103−CD11b+ cDCs in vivo [5] and
it was recently reported that CD64− DCs are virtually absent from
the small intestine (SI) of Flt3L−/− mice [1], although this study
did not further categorize the cells based on CD103 expression.
In contrast, in WT:Flt3−/− mixed BM chimeras, the numbers of
CD103−CD11b+ LP cDCs that derived from Flt3−/− BM were only
partially reduced compared with WT BM-derived CD103−CD11b+
LP cDCs [4].
Antigen uptake and migration to MLNs by
SI LP cDCs
Sampling of luminal Ag by migratory LP cDC subsets
In their role as professional antigen presenting cells, intestinal
DCs survey the content of the intestine and transport Ags to the
MLNs where they initiate adaptive immune responses. Exactly
how intestinal cDCs gain access to luminal Ag and whether
intestinal cDC subsets sample soluble and particulate luminal
Ags by similar routes is currently unclear. Initial studies sug-
gested that CD11c+ cells could extend transepithelial dendrites
(TEDs) through tight junctions in the epithelium to capture lumi-
nal bacteria [37]. TED formation by CX3CR1+ cells was observed
ex vivo in the terminal ileum of CX3CR1+/gfp mice and this
appeared to be CX3CR1-dependent [38]. The functional relevance
of these findings remains unclear, as although CX3CR1-dependent
TEDs appeared to be required for uptake of invasion-deficient
Salmonella [38], invasive Salmonella usually gain entry to the
intestine primarily via microfold cells in PPs and ILFs [39–41]
and CX3CR1-dependent TEDs were not required for the uptake of
invasive Salmonella nor noninvasive Aspergillus spores [42]. Addi-
tionally most CX3CR1+ cells in the intestine are tissue resident
Ms, rather than cDCs [1,2,43].
Two recent multiphoton microscopy studies used refinedmeth-
ods for identifying hematopoietic Ag sampling cells in the intestine
[44,45]. Both studies performed direct in vivo imaging of the intes-
tine to help limit the potential artifacts that had been a concern
in previous ex vivo approaches and CD11c+/yfp x CX3CR1+/gfp
mice to allow distinction between CX3CR1+CD11c+ Ms and
CX3CR1−CD11c+ cDCs. McDole et al. [44] failed to detect TED
extension by LP cDCs, but instead identified goblet cell-associated
Ag passages that appeared to pass soluble dextran and proteins
from the lumen to underlying GFP−YFPhi cells. This route is
unlikely to be involved in uptake of particulate Ag, such as luminal
bacteria, as beads >0.02 μm diameter could not transit through
GAPs. Similarly, Farache et al. [45] failed to observe LP cDCs
extending TEDs but, in contrast toMcDole et al., they noted a small
population of CD103+ DCs within the epithelium itself, whose
numbers increased in a CD103- and CCR6-independent manner
following luminal administration of Salmonella. These intraepithe-
lial CD103+ cDCs could be visualized extending intraepithelial
dendrites into the lumen sampling Salmonella [45]. These find-
ings are in agreement with previous reports suggesting that low
numbers of CD103+ cDCs are present in the epithelium at steady
state, but increase during inflammation [11, 46, 47]. Consistent
with earlier work suggesting that orally administered protein Ag
is taken up preferentially by CX3CR1high Ms [43], Farache et al.
[45] found that intraepithelial CD103+ DCswere poor at capturing
soluble Ag, compared with CX3CR1high Ms, which formed occa-
sional TEDs. While the reason for the discrepant findings between
the two studies regarding uptake of soluble Ag is not immediately
apparent, Farache et al. [45] suggested it may reflect the ways
in which the groups tuned their imaging systems to quantify YFP
and GFP co-expression. McDole et al. [44] identified LP cDCs as
GFP−YFPhigh cells whereas Farache et al. [45] identified them as
GFP−YFPint cells and provided data to suggest that YFPhigh cells
were in fact CX3CR1high Ms. Clearly, further studies are required
to assess the mechanisms by which intestinal cDCs acquire solu-
ble and particulate derived luminal Ag, and whether the differ-
ent LP cDC subsets perform overlapping or distinct roles in these
processes.
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Migration of SI cDCs to draining MLNs
After acquiring Ag, intestinal cDCs migrate to draining MLNs
in a CCR7-dependent manner [48–51]. In earlier studies we
provided strong, although indirect evidence that MLN CD103+
cDCs derive from the intestinal LP [49, 52]. By ex vivo confo-
cal imaging of intestinal lymphatics and sampling of intestinal
draining lymph, we [43] subsequently identified CD103+ DCs as
the major migratory cDC population in intestinal lymph. More
recently, by cannulating thoracic duct lymph from mesenteric
lymphadenectomized mice, Cerovic et al. [5] confirmed that 75–
85% of CD11c+MHCII+ cells in steady-state intestinal lymph are
CD103+ cDCs. CD103+CD11b+ and CD103+CD11b− cDCs were
present in intestinal steady-state lymph at a ratio of ∼1.5–1,
approximating that found in the MHCIIhigh migratory cDC pop-
ulation in MLNs. The remaining CD11c+MHCII+ cells were CCR7-
expressing CD103− cDCs, the majority of which were CD11b+ [5].
Together, these data indicate that all subsets of bona fide LP cDCs
migrate via afferent lymph to the MLN in the steady state.
Consistent with their lack of CCR7 expression and their absence
from MLNs, CX3CR1high Ms were not found in intestinal drain-
ing afferent lymph in the studies by Schulz et al. [5, 43] and
Cerovic et al. [5,43]. Contrary to these findings, Diehl et al. [53]
recently reported CD103−CX3CR1high cells in intestinal lymph in
the steady state. While the reason for these discrepant findings
is currently unclear, it is unlikely to be due to differences in the
microbiota, as similar numbers of putative CX3CR1high cells were
observed in steady-state lymph following treatment of mice with
broad spectrum antibiotics. One possible explanation is that the
CX3CR1high cells detected by Diehl et al. [53] are in fact CX3CR1int
cells and represent the CD103− CD11b+ cDC subset of bona fide
cDCs identified by Cerovic et al. [5].
Role of intestinal cDC subsets in the
initiation of adaptive immune responses
LP cDCs in the priming of naı¨ve CD4+ and CD8+ T cells
Migratory intestinal LP cDCs carry soluble and particulate Ags to
the MLNs [11, 54, 55], where they are believed to play a critical
role in the initiation of adaptive immune responses. Consistent
with this idea, CD103+ cDCs isolated from the MLNs shortly after
oral administration of soluble Ag induce Ag-specific proliferation
of CD4+ and CD8+ T cells ex vivo [52,56] and CCR7-deficientmice
fail to mount T-cell responses in MLNs after oral Ag administration
[49,57]. Recent studies analyzing FACS-purified cDC subsets from
the SI, MLNs, and intestinal lymph suggest that all migratory cDC
subsets can induce proliferation and functional polarization of
na¨ıve CD4+ T cells in vitro [5, 13, 24]. In addition, consistent
with their developmental relationshipwith lymphoid tissue CD8α+
DCs and CD103+CD8α+ DCs in other peripheral tissues [58–60],
CD103+CD11b− LP DCs appear superior to CD103+CD11b+ DCs
at cross-presenting Ag to CD8+ T cells in vitro [5]. Despite these
findings, the role that particular intestinal migratory cDC subsets
play in priming na¨ıve CD4+ and CD8+ T cells in MLN in vivo
is currently unclear, but could potentially be explored utilizing
mice whose DCs are deficient in the distinct transcription factors
described above.
LP cDCs in the generation of gut-homing T cells
One of the characteristic features of the intestinal immune system
is its anatomical compartmentalization, in which T and B cells
primed in the GALT and MLNs are imprinted with the specific abil-
ity to return to the mucosa. In the case of the SI, this is dependent
on the induction of the gut-homing molecules CCR9 and α4β7 on
primed T cells, which are receptors for the chemokine CCL25 and
the vascular adhesion molecule mucosal vascular addressin cell
adhesion molecule 1 (MADCAM-1), respectively (for reviews see
[61–63]). Early studies by us and others demonstrated that small
intestinal and MLN CD103+ cDCs display an enhanced ability to
induce CCR9 and α4β7 on responding T cells in vitro, compared
with DCs isolated from other tissues [49, 52, 64]. Subsequently,
MLN CD103+ cDCs were shown to have an enhanced ability to
generate the vitamin A metabolite, retinoic acid (RA) [52,65,66],
which is essential for gut-tropic T-cell generation in vitro and in
vivo [65, 67]. Cerovic et al. [5] recently observed that all migra-
tory cDC subsets including the small fraction of CD103− cDCs
in intestinal lymph metabolize vitamin A and induce gut-homing
receptors on responding T cells in vitro, a finding that is consis-
tent with the idea that migratory cDCs are imprinted with the
ability to metabolize Vitamin A from signals they receive in the
SI mucosa (for recent review see [68]). In contrast to these in
vitro studies, the role of SI DC-derived RA in the generation of
gut-tropic T cells in vivo remains unclear. Thus, intestinal LP and
MLN T cells from mice lacking Batf3-dependent CD103+CD11b−
MLN DCs have normal expression of CCR9 and α4β7 [16], and we
have recently shown that mice selectively lacking CD103+CD11b+
MLN DCs maintain their ability to induce gut-homing receptors
on CD4+ T cells in vivo [24]. These latter studies suggest that RA
derived from either subset is sufficient to drive gut-tropic T-cell
generation in vivo, or that there are other non-DC derived sources
of RA, such as from MLN stromal cells [69, 70], that fulfill this
function.
LP cDCs in Th cell differentiation
Inducible FoxP3+ Treg-cell generation
The MLN is a site that favors the differentiation of inducible
FoxP3+ regulatory T (iTreg) cells [56, 71]. CCR7, FoxP3+ Treg
cells, and MLNs are all required for the induction of tolerance
to soluble luminal Ag [57, 72], indicating a key role for migra-
tory LP-derived cDCs in iTreg-cell generation. Consistent with this
idea, small intestinal and MLN CD103+ cDCs display an enhanced
capacity to generate iTreg cells from na¨ıve precursors in vitro
compared with other cDC subsets, in part through their ability
C© 2013 The Authors. European Journal of Immunology published by
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to generate RA ([56, 71] and reviewed in [73]). Mechanistically,
RA alone fails to induce iTreg-cell differentiation but acts in syn-
ergy with TGF-β to enhance iTreg-cell generation in vitro. Indeed
inhibition of RA receptor signaling prevents the enhanced capac-
ity of CD103+ cDCs to drive Treg-cell differentiation in the pres-
ence of TGF-β [56,71,74]. These original studies however did not
distinguish between CD103+CD11b+ and CD103+CD11b− DCs.
Notably, DC-specific deletion of αvβ8, an integrin that activates
latent TGF-β, leads to a reduction in FoxP3+ Treg-cell numbers and
systemic autoimmunity [75] and CD103+CD11b− cDCs appear to
be the only intestinal cDCs that express αvβ8 (Scott and Persson,
unpublished observations). Despite these findings, Batf3−/− mice,
which lack CD103+CD11b− cDCs, have normal numbers of intesti-
nal FoxP3+ Treg cells [16]. We and others have also demonstrated
recently that mice with a severe and selective reduction in migra-
tory MLN CD103+CD11b+ cDCs have normal numbers of FoxP3+
Treg cells in the SI and colon [24, 25], with equivalent ratios of
Helios+ and neuropilin+ Treg cells when compared with WT mice
[24]. Interpretation of these results is complicated by a lack of
clear markers to distinguish thymically derived natural Treg cells
from iTreg cells in the intestinal mucosa. In fact, recent findings
suggest that the majority of Treg cells in the intestine represent
natural Treg cells [76, 77] and thus the contribution of distinct
intestinal migratory cDC subsets in driving iTreg-cell differentia-
tion in MLN in vivo remains unclear.
Mucosal Th1/Th17 development
The steady-state intestinal LP contains a large pool of effec-
tor/memory CD4+ T cells with specificities against enteric micro-
bial Ags and other luminal content [78]; these CD4+ T cells include
Th1 cells and the largest population of Th17 cells in the body.
While it was thought initially that intestinally derived CD103+
cDCs preferentially induced Treg-cell responses [79, 80], mount-
ing evidence suggests that these DCs also play important roles
in driving effector Th-cell differentiation in intestinal draining
LNs. Moreover it appears that the individual subsets of intesti-
nal cDCs may play distinct roles in promoting different arms of
the mucosal adaptive immune response. In vitro studies indicate
that both CD103+CD11b+ and CD103+CD11b− cDCs can drive
Th1 polarization [20], while CD103+CD11b− SI DCs are effective
at driving IFN-γ production by CD8+ T cells ([5], our unpub-
lished observations). Conversely, CD103+CD11b+ cDCs appear
more efficient at inducing Th17 polarization than CD103+CD11b−
cDCs [13,20,24,81]. More recently, CD103− cDCs from intestinal
steady-state lymph were suggested to be superior to both CD103+
subsets at inducing both Th1 and Th17 cells in vitro [5]. We,
and others, recently provided evidence that intestinal cDC subsets
also play differential roles in the initiation of adaptive immune
responses in vivo. Specifically, mice with a selective reduction in
SI CD103+CD11b+ cDC numbers and an almost complete loss of
these cells in intestinal draining MLNs, have reduced levels of
endogenous Th17 cells in the SI, MLN, and colon [4,24], despite
normal total CD4+ T-cell and Th1-cell numbers [24]. Moreover
we found that adoptively transferred CD4+ T cells failed to dif-
ferentiate into Th17 cells in the MLNs of these mice following
immunization with Ag and LPS and αCD40, while Th1-cell dif-
ferentiation was unaffected. Mechanistically, it appeared that the
selective absence of migratory CD103+CD11b+ cDCs in the MLNs
resulted in reduced levels of IL-6, and that this was critical for
driving Th17 differentiation in this location [24].
The in vivo signals that imprint DCs with the ability to gener-
ate effector T cells in the healthy intestine are unclear, although
a role for pattern recognition receptors including toll-like recep-
tors (TLRs) and MyD88 signaling has been suggested [82, 83].
Indeed ligands for several TLRs including TLR2, TLR5, and TLR9
induce IL-6 production by CD103+CD11b+ DCs in vitro and pro-
mote their ability to generate Th17-cell differentiation [5,20,24].
In this regard, it is interesting to note that CD103+CD11b+ cDCs
and CD103+CD11b− cDCs express a partially overlapping and par-
tially distinct array of pattern recognition receptors [20,81,84,85],
suggesting that they may respond differentially to microbial sig-
nals in the intestinal lumen.
Summary and concluding remarks
Intestinal DCs are a crucial link between the innate and adaptive
immune responses and thus provide an attractive target for thera-
peutic manipulation of the intestinal immune response. Although
similar levels of CD11c and MHCII expression by intestinal DCs
and Ms have impeded reliable characterization of DCs in the
past, recent advances in phenotyping now allow these cells to be
more precisely discriminated. As a result, it is now believed that
there are at least three populations of bona fide DCs in the murine
intestinal LP: two CD103-expressing cDC subsets, CD103+CD11b+
and CD103+CD11b− cDCs, which derive from committed cDC
precursors; and a more recently described CD103−CD11b+ pop-
ulation whose functions and origins remain to be characterized
fully. The recent development of specific knock out mouse models
with selective reduction in individual intestinal cDC populations
has also allowed researchers to start addressing the functions of
individual intestinal cDC subsets in the regulation of adaptive
immune responses in vivo. Initial studies with these mice have
demonstrated that the previous assertions that CD103+ cDCs were
inherently tolerogenic are incorrect, and that, for example intesti-
nal CD103+CD11b+ cDCs play an important role in driving Th17
differentiation in the MLNs [24]. It remains unclear if each cDC
subset is hardwired to generate specific aspects of the T-cell pool
in vivo, or if plasticity of the subsets can allow each to drive dif-
ferent forms of T-cell responses as required. If so, it seems likely
that this plasticity will be determined by signals from the local
environment. As well as identifying the factors involved, it will
be important to determine at what stage they act in cDC devel-
opment. For instance, do local signals act on newly arrived pre-
cursors and predetermine the functions of their progeny, or do
mature cDCs adjust when they encounter different contexts in the
tissues? Finally it is important to note that progress has also been
made in identifying cDC subsets in the human intestinal LP. The
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA Weinheim.
www.eji-journal.eu
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majority of cDCs in the healthy SI also express CD103 and can
be similarly divided into two subsets [24], a major population of
SIRPα+ IRF4-expressing cDCs that we speculate are equivalent to
murine intestinal CD103+CD11b+ DCs, and a minor population
of CD141+ cDCs that are likely equivalents of CD103+CD11b−
DCs [86–88]. It remains to be seen if an equivalent to murine
CD103− cDCs exists in the human intestine. Determining whether
these human intestinal cDC subsets function in a similar way to
their murine counterparts will be important if these cells are to be
exploited for the treatment and/or prevention of human inflam-
matory bowel diseases and in the development of mucosal vac-
cines.
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